Affiliation:
1. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of the Russian Federation; Center for Theoretical Problems of Physical and Chemical Pharmacology, Russian Academy of Sciences
2. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of the Russian Federation; Center for Theoretical Problems of Physical and Chemical Pharmacology, Russian Academy of Sciences; Lomonosov Moscow State University
Abstract
Drug delivery using natural biological carriers, especially erythrocytes, is a rapidly developing field. Erythrocytes can act as carriers with the gradual release of a pharmacological agent, as bioreactors with encapsulated enzymes, or as a tool for targeted delivery of drugs to target organs especially tissue macrophages, liver and spleen. To date, red blood cells have been studied as carriers for a wide range of drug compounds, such as enzymes, antibiotics, anti-inflammatory, antiviral drugs, etc. The review is devoted to the advantages of erythrocytes as carriers for the delivery of drugs loaded into the erythrocyte, or related to its surface, and defines the main directions of research on erythrocytes carriers of biologically active substances. Particular attention is paid to in vivo studies that reveal the potential of carrier erythrocytes for clinical use.
Publisher
Fund Doctors, Innovations, Science for Children
Subject
Oncology,Hematology,Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health
Reference57 articles.
1. Ataullakhanov F.I., Borsakova D.V., Protasov E.S., Sinauridze E.I., Zeinalov A.M. Eritrotsit: meshok s gemoglobinom ili zhivaya, aktivnaya kletka? Voprosy gematologii/onkologii i immunopatologii v pediatrii 2018; 17 (1): 108–16.
2. Koleva L., Bovt E., Ataullakhanov F., Sinauridze E. Erythrocytes as carriers : from drug delivery to biosensors. Pharmaceutics 2020; 12 (3): 276.
3. Pierigè F., Bigini N., Rossi L., Magnani M. Reengineering red blood cells for cellular therapeutics and diagnostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2017; 9 (5): e1454. DOI: 10.1002/wnan.1454
4. Fernandes H.S., Silva Teixeira C.S., Fernandes P.A., Ramos M.J., Cerqueira N.M.F.S.A. Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections. Expert Opin Ther Pat 2017; 27 (3): 283–97.
5. Rytting M.E. Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients. Blood Lymphat Cancer Targets Ther 2012; 2: 117–24.